Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df874e3cf88adba3792dc9d5b5776180 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4706 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5743 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2014-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f5300640d077c1646c49574b6e6e87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8fe00122dfa9e435eead7ede087094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0848621bc31d043e3c5b2620d44d2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b169aa991a46744893f2b7e80bab368 |
publicationDate |
2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016116480-A1 |
titleOfInvention |
Prognosis and predictive biomarkers and biological applications thereof |
abstract |
The present invention relates to a method of evaluating the sensitivity or resistance of a cancer cell to an antitumoral therapeutic treatment. It further relates to the treatment of a cancer with an inhibitor of the eiF4F complex used for the sensitisation of said cancer to an antitumoral therapeutic treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021003192-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113372407-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113372407-A |
priorityDate |
2013-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |